PYCR1 and cancer: The benefit of targeting proline metabolism to reduce cancer growth has been evaluated experimentally with a large body of evidence showing that genetic inactivation of PYCR1 reduces growth of diverse cancer types (Loayza‐Puch et al, 2016; Elia et al, 2017; D’Aniello et al, 2020).